Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SonoVue-enhanced HyCoSy for tubal obstruction in infertility
CTR20220971Phase 3Completed
- Sponsor
- Bracco S.p.A.
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sulfur hexafluoride in female infertility, sponsored by Bracco S.p.A. Primary endpoints: Sensitivity of SonoVue-enhanced HyCoSy for detection of fallopian tube obstruction at the tubal level and Specificity of SonoVue-enhanced HyCoSy for detection of fallopian tube obstruction at the tubal level. Started Apr 2022; status: completed.
02
Drugs
sulfur hexafluoride
03
Conditions
female infertility
Beyond the preview
Go deeper on CTR20220971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220971.